Shopping cart processing ...
Your cart0
Products 0
Price $0.00
Bestsellers Pill categories
Customer Support 24/7
usa canada USA
uk UK
au AU
Live Chat 24/7
Customer Support 24/7
USA/Canada Toll Free USA
Customer Support 24/7
usacanada USA
uk UK
au AU
We accept
  • Visa
  • MasterCard
  • Amex
  • JCB
Your cart: $0.00 (0 items)

Categories list

Choosing us you get:

  • Reliable supplier
  • Low Internet prices
  • Free bonus pills
  • Discount on all future orders
  • Discreet package
  • SSL secure orders
Worldwide Shipping!


  • Gary Riley Richmond, VA, USA
    Great thanks to your site – for drugs quality, timely delivery, nice support service and low prices. I am your constant customer and recommend you all.
More info »


Precose is a glucosidase inhibitor that is used along with a good diet and regular exercise to cure Type II diabetes.

Brand: Acarbose

Availability: In Stock
Average Delivery Time: 9 Days
Exp. Date: June 2024
Package Price Per pill Save Order
Precose 50 mg
360 pills - 50 mg
+ 8 free Viagra 100 mg, 5% discount for future orders
$249.97 $0.69 $79.73 Add to cart
270 pills - 50 mg
+ 4 free Viagra 100 mg, 3% discount for future orders
$189.93 $0.70 $57.35 Add to cart
180 pills - 50 mg
+ 4 free Viagra 100 mg, 3% discount for future orders
$130.51 $0.73 $34.34 Add to cart
120 pills - 50 mg $90.91 $0.76 $18.99 Add to cart
90 pills - 50 mg $69.99 $0.78 $12.44 Add to cart
60 pills - 50 mg $54.95 $0.92 No Add to cart
Precose 25 mg
360 pills - 25 mg
+ 4 free Viagra 100 mg, 3% discount for future orders
$189.23 $0.53 $86.47 Add to cart
270 pills - 25 mg
+ 4 free Viagra 100 mg, 3% discount for future orders
$145.81 $0.54 $60.97 Add to cart
180 pills - 25 mg $99.05 $0.55 $38.80 Add to cart
120 pills - 25 mg $68.41 $0.57 $23.49 Add to cart
90 pills - 25 mg $52.93 $0.59 $16.00 Add to cart
60 pills - 25 mg $45.95 $0.77 No Add to cart

Product description

Drug Name

Precose (Acarbose)

Pharmacological action

Oral hypoglycemic drug. Competitive inhibitor of intestinal alpha-glucosidases. Inhibits the process of biotransformation of sucrose and starch to well-absorbed monosaccharides, thus reducing postprandial hyperglycemia and reducing daily blood glucose fluctuations. Unlike sulfonylurea derivatives, it has no stimulating effect on the pancreas.


About 35% of the administered dose is absorbed as metabolites, less than 2% - in active form. Bioavailability is 1-2%. Metabolized in the gastrointestinal tract mainly by intestinal bacteria and only partially by digestive enzymes to form at least 13 compounds as sulfate, methyl and glucurone conjugates.

One metabolite, a product of the cleavage of the glucose molecule in acarbose, has the ability to inhibit alpha-glucosidase. After oral administration, there are 2 plasma Cmax peaks of acarbose, averaging 52.2±15.7 µg/L and 586.3±282.7 µg/L and observed after 1.1±0.3 h and 20.7±5.2 h, respectively. The appearance of the second peak is apparently due to the absorption of products of bacterial decomposition from the deep parts of the small intestine. Cmax in patients with renal insufficiency (CK < 25 ml/min) is 5 times higher, in elderly patients - 1.5 times higher. Vd is 0.32 l/kg. T1/2 of acarbose in the distribution phase is 3.7±2.7 h, in the excretion phase - 9.6±4.4 h, respectively; 51% of active substance is excreted through the intestine; 1.7% unchanged and as an active metabolite and 34% as metabolites - by kidneys.

Contraindications for use

Chronic intestinal diseases with marked indigestion and absorption disorders; states accompanied with flatulence (Remheld syndrome, large hernias, intestinal stenosis, intestinal ulcers); severe renal failure (CK <25 ml/min); pregnancy, lactation (breast-feeding); age under 18 years; hypersensitivity to acarbose.

Administration during pregnancy and lactation

Contraindications for use during pregnancy and lactation.

Administration in patients with liver dysfunction

Contraindication: liver dysfunction. It is recommended to monitor the liver transaminase activity in plasma during long-term (more than 6 months) administration of acarbose at a dose of 600 mg/day.

Administration in children

Contraindication: age under 18 years.

Indications of active substance Precose (Acarbose)

Treatment of type 2 diabetes in combination with diet therapy (as monotherapy or in combination with other hypoglycemic preparations, including insulin).

Prevention of type 2 diabetes in patients with impaired glucose tolerance in combination with diet and exercise.

Dosing regimen

For oral administration, the initial dose is 50 mg 3 times a day; further, depending on the treatment regimen and the patient's individual response, the dose may be increased to 100-200 mg 3 times a day. The treatment is prolonged.